Clinical Trial Update: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) [Phase 4]

View source ↗

Summary

This document provides an update on the Phase 4 long-term safety study of Sodium oligomannate capsules (GV-971) for Alzheimer's disease, noting that the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• GV-971 (Sodium oligomannate)

Snippet

Sponsor: Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Conditions: Alzheimer Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING